Emergent BioSolutions, Inc. (EBS)
5.17
+0.09
(+1.77%)
USD |
NYSE |
Aug 24, 16:00
5.17
0.00 (0.00%)
After-Hours: 20:00
Emergent BioSolutions Price to Book Value : 0.7768 for Aug. 24, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| August 21, 2026 | 0.7633 |
| August 20, 2026 | 0.7243 |
| August 19, 2026 | 0.7348 |
| August 18, 2026 | 0.7002 |
| August 17, 2026 | 0.6762 |
| August 14, 2026 | 0.6897 |
| August 13, 2026 | 0.6747 |
| August 12, 2026 | 0.6837 |
| August 11, 2026 | 0.6687 |
| August 10, 2026 | 0.6717 |
| August 07, 2026 | 0.7273 |
| August 06, 2026 | 0.7979 |
| August 05, 2026 | 1.133 |
| August 04, 2026 | 1.138 |
| August 03, 2026 | 1.114 |
| July 31, 2026 | 1.085 |
| July 30, 2026 | 1.091 |
| July 29, 2026 | 1.104 |
| July 28, 2026 | 1.098 |
| July 27, 2026 | 1.101 |
| July 24, 2026 | 1.091 |
| July 23, 2026 | 1.127 |
| July 22, 2026 | 1.139 |
| July 21, 2026 | 1.150 |
| July 20, 2026 | 1.156 |
| Date | Value |
|---|---|
| July 17, 2026 | 1.146 |
| July 16, 2026 | 1.156 |
| July 15, 2026 | 1.186 |
| July 14, 2026 | 1.127 |
| July 13, 2026 | 1.204 |
| July 10, 2026 | 1.210 |
| July 09, 2026 | 1.229 |
| July 08, 2026 | 1.223 |
| July 07, 2026 | 1.246 |
| July 06, 2026 | 1.229 |
| July 02, 2026 | 1.244 |
| July 01, 2026 | 1.244 |
| June 30, 2026 | 1.259 |
| June 29, 2026 | 0.8378 |
| June 26, 2026 | 0.8447 |
| June 25, 2026 | 0.7902 |
| June 24, 2026 | 0.8348 |
| June 23, 2026 | 0.7932 |
| June 22, 2026 | 0.7773 |
| June 18, 2026 | 0.7922 |
| June 17, 2026 | 0.8061 |
| June 16, 2026 | 0.7674 |
| June 15, 2026 | 0.8209 |
| June 12, 2026 | 0.8239 |
| June 11, 2026 | 0.8308 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Exelixis, Inc. | 7.366 |
| Capricor Therapeutics, Inc. | 1.607 |
| ADMA Biologics, Inc. | 5.269 |
| Akebia Therapeutics, Inc. | 9.776 |
| Arcutis Biotherapeutics, Inc. | 14.11 |
Price to Book Value Related Metrics
| PS Ratio | 0.3641 |
| Price to Free Cash Flow | 3.265 |
| Price | 5.17 |
| Earnings Yield | -68.74% |
| Market Cap | 265.22M |
| Operating PE Ratio | 2.049 |